On Wednesday, Spectranetics Corp (NASDAQ:SPNC)’s shares declined -1.57% to $16.25.
The Spectranetics Corporation (SPNC) declared that its administration will be presenting at the Canaccord Genuity Growth Conference on August 12, 2015 in Boston.
The Spectranetics Corporation, together with its auxiliaries, develops, manufactures, markets, and distributes single-use medical devices used in minimally invasive procedures in the cardiovascular system. Its products are used to cross, prepare, and treat arterial blockages in the legs and heart, and to remove pacemaker and defibrillator cardiac leads.
Capstone Turbine Corporation (NASDAQ:CPST)’s shares dropped -4.37% to $0.317.
Capstone Turbine Corporation (CPST), the world’s leading clean technology manufacturer of microturbine energy systems, will release financial results for the first quarter of fiscal year 2016 ended June 30, 2015 at 1:45 p.m. Pacific Time (4:45 p.m. Eastern) on August 6, 2015.
Capstone Turbine Corporation develops, manufactures, markets, and services microturbine technology solutions for use in stationary distributed power generation applications worldwide. It offers microturbine units, subassemblies, components, and various accessories for applications, counting cogeneration comprising combined heat and power (CHP) and integrated CHP, in addition to combined cooling, heat, and power; and renewable energy, natural resources, and critical power supply.
At the end of Wednesday’s trade, Stryker Corporation (NYSE:SYK)‘s shares surged 1.62% to $103.12.
Stryker Corporation (SYK) declared that its Board of Directors has declared a quarterly dividend of $0.345 per share payable on October 30, 2015, to shareholders of record at the close of business on September 30, 2015, representing an enhance of 13% as compared to the preceding year, and unchanged from the previous quarter.
Stryker is one of the world`s leading medical technology companies and together with our customers, we are driven to make healthcare better. The Company offers a diverse array of innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine, which assist improve patient and hospital outcomes. Stryker is active in over 100 countries around the world. Please contact us for m
Stryker Corporation, together with its auxiliaries, operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment offers implants used in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment provides surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling and emergency medical equipment, and reprocessed and remanufactured medical devices, in addition to other medical device products for use in various medical specialties.
LGI Homes Inc (NASDAQ:LGIH), ended its Wednesday’s trading session with 23.33% gain, and closed at $23.21.
LGI Homes, Inc. (LGIH) declared results for the second quarter 2015 and the six months ended June 30, 2015.
Second Quarter 2015 Highlights and Comparisons to Second Quarter 2014
- Net Income of $14.0 million, or $0.70 Basic EPS and $0.66 Diluted EPS.
- Net Income Before Income Taxes raised 52.8% to $21.2 million.
- Home Closings raised 28.9% to 853 homes.
- Home Sales Revenues raised 49.3% to $158.8 million.
- Average Home Sales Price raised 15.8% to $186,197.
- Adjusted Gross Margin (non-GAAP) as a Percentage of Home Sales Revenues raised 30 basis points to 28.2%.
- Active Selling Communities at quarter-end raised to 45 from 31.
- Total Owned and Controlled Lots raised to 22,192 lots.
LGI Homes, Inc. designs, constructs, markets, and sells homes in Texas, Arizona, Florida, Georgia, New Mexico, Colorado, North Carolina, and South Carolina, the United States. The company was founded in 2003 and is headquartered in The Woodlands, Texas.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
